Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for ''
published presentations and documents on DocSlides.
Developing a Clinico-Molecular Test for Individualized Treatment of Ovarian Cancer: The interplay o
by genderadidas
. Boris . Winterhoff. , MD, MS. 1,11,12. , . Ste...
Antiangiogenic Agents in Advanced NSCLC
by ellena-manuel
Jared Weiss, MD . Assistant . Professor of Medici...
Please note, these are the actual video-recorded proceeding
by lindy-dunigan
Moderator. Neil Love, MD. Jessica Mitchell, RN, C...
Pathophysiology of diabetic retinopathy and diabetic macular edema
by jane-oiler
Charles C. Wykoff, MD, PhD, FACS. Physician, Reti...
Inaugural Recurrent Respiratory
by deborah
Papillomatosis Roundtable. Executive Summary. Tabl...
8Wagner S WarmuthMetz M Emser A Treatment options9Wolff JE Molen
by brown
2269 patients as an antiangiogenic agent (16). The...
1. In general, when do you typically order mutation testing for your patients with newly diagnosed
by opelogen
At initial diagnosis . 0. At first relapse . 0. At...
The Role of Antiangiogenic Agents
by luanne-stotts
The Role of Antiangiogenic Agents in the Changin...
Treatment in Advanced Non-Small Cell Lung Cancer
by oconnor
. 5. th. most commonly diagnosed cancer in Austra...
Please note, these are the
by markes
actual. . video-recorded proceedings from the . l...
As it pertains to the last patient in your practice who died of metastatic nonsquamous
by kittie-lecroy
non-small cell lung cancer (NSCLC) . with no targ...
Shin-Ichi Miyatake,
by aaron
MD., Ph.D.. Shinji Kawabata, Motomasa . Furuse. ...
Using Non-targeted Therapies in Targeted Lung Cancer Popula
by ellena-manuel
Nathan Pennell, M.D., Ph.D.. September 6, 2014. O...
Load More...